Oncology drug-companion diagnostic combinations
With the development of trastuzumab for metastatic breast cancer a new era began in cancer drug development. The drug-diagnostic codevelopment model with its clinical enrichment trial design has enabled development of target specific drugs for molecular defined subsets of patients. Since the simulta...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2021-01-01
|
| Serie: | Cancer Treatment and Research Communications |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S246829422100188X |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|